Evidence map›Paper›PMID 42320893›Full record

ReviewJournal of the American Association for Laboratory Animal Science : JAALAS2026

Machine Learning in Nonhuman Primate Models of Infectious Diseases: Current Applications and Future Perspectives.

Bon-Sang Koo, Remco A Nederlof, Eunsu Jeon, Gyu-Seo Bae, Dae-Soo Kim, Jung Joo Hong, Jaco Bakker

Abstract readReview
In one paragraph

Review in Journal of the American Association for Laboratory Animal Science : JAALAS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bon-Sang KooNational Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.
Remco A NederlofIndependent Researcher, Bergambacht, The Netherlands.
Eunsu JeonNational Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.
Gyu-Seo BaeNational Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.
Dae-Soo KimDepartment of Biomolecular Science, KRIBB School of Bioscience, University of Science and Technology, Daejeon, Republic of Korea.
Jung Joo HongNational Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.
Jaco BakkerAnimal Science Department, Biomedical Primate Research Centre, Rijswijk, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The amount of biologic data produced by biomedical research has increased significantly in both volume and complexity in recent years. Advances in computational power have increasingly enabled the use of machine learning (ML) to analyze and predict patterns from large-scale, complex biologic datasets. In nonhuman primate (NHP) infectious disease models, such high-dimensional datasets containing a large number of features are often obtained by next-generation sequencing-based multiomics and immunologic analyses. As a result, ML is particularly valuable for effective analysis and predictive modeling in this context. This review demonstrates that the application of ML in NHP infectious disease models has increased over time. Ensemble methods, particularly random forest, have emerged as the most frequently used algorithms, followed by regression and clustering approaches. Logistic regression and hierarchical clustering were the most commonly applied regression and clustering methods, respectively. These techniques are primarily used for vaccine response prediction, biomarker discovery, disease progression analysis, gene and pathway identification, and immune response characterization. Despite this increasing trend, the overall adoption of ML in NHP infectious disease models remains limited, which may reflect gaps in familiarity and computational expertise among researchers. Recent advances in generative artificial intelligence and user-friendly analytical platforms are expected to improve accessibility and promote broader adoption. This review aims to support understanding and facilitate wider application of ML in NHP infectious disease models.

Indexed as

AI, artificial intelligenceANN, artificial neural networkCNN, convolutional neural networkDBSCAN, density-based spatial clustering of applications with noiseDNN, deep neural networkFCM, fuzzy c-meansGNN, graph neural networkKNN, k-nearest neighborsLASSO, least absolute shrinkage and selection operatorLDA, linear discriminant analysisML, machine learningMLP, multilayer perceptronNHP, nonhuman primatePCA, principal component analysisQDA, quadratic discriminant analysisRNN, recurrent neural networkSARS-CoV-2, severe acute respiratory syndrome coronavirus 2SIV, simian immunodeficiency virusSVM, support vector machinet-SNE, t-distributed stochastic neighbor embeddingUMAP, uniform manifold approximation and projectionXGBoost, extreme gradient boosting

Identifiers

PMID42320893
PMCPMC13446406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.